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activator, in the developing and adult nervous system of the
mouse
Abstract
Neuroserpin is a serine protease inhibitor of the serpin family that has been identified as an axonally
secreted glycoprotein in neuronal cultures of chicken dorsal root ganglia. To obtain an indication for
possible functions of neuroserpin, we analyzed its expression in the developing and the adult CNS of the
mouse. In the adult CNS, neuroserpin was most strongly expressed in the neocortex, the hippocampal
formation, the olfactory bulb, and the amygdala. In contrast, most thalamic nuclei, the caudate putamen,
and the cerebellar granule cells were devoid of neuroserpin mRNA. During embryonic development,
neuroserpin mRNA was not detectable in neuroepithelia, but it was expressed in the differentiating
fields of most CNS regions concurrent with their appearance. In the cerebellum, the granule cells and a
subgroup of Purkinje cells were neuroserpin-positive during postnatal development. As a further step
toward the elucidation of neuroserpin function, we performed a study to identify potential target
proteases. In vitro, neuroserpin formed SDS-stable complexes and inhibited the amidolytic activity of
tissue plasminogen activator, urokinase, and plasmin. In contrast, no complex formation with or
inhibition of thrombin was found. Expression pattern and inhibitory specificity implicate neuroserpin as
a candidate regulator of plasminogen activators, which have been suggested to participate in the
modulation or reorganization of synaptic connections in the adult. During development, neuroserpin
may attenuate extracellular proteolysis related to processes such as neuronal migration, axogenesis, or
the formation of mature synaptic connections.
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Neuroserpin is a serine protease inhibitor of the serpin family
that has been identified as an axonally secreted glycoprotein in
neuronal cultures of chicken dorsal root ganglia. To obtain an
indication for possible functions of neuroserpin, we analyzed its
expression in the developing and the adult CNS of the mouse.
In the adult CNS, neuroserpin was most strongly expressed in
the neocortex, the hippocampal formation, the olfactory bulb,
and the amygdala. In contrast, most thalamic nuclei, the cau-
date putamen, and the cerebellar granule cells were devoid of
neuroserpin mRNA. During embryonic development, neuroser-
pin mRNA was not detectable in neuroepithelia, but it was
expressed in the differentiating fields of most CNS regions
concurrent with their appearance. In the cerebellum, the gran-
ule cells and a subgroup of Purkinje cells were neuroserpin-
positive during postnatal development. As a further step toward
the elucidation of neuroserpin function, we performed a study
to identify potential target proteases. In vitro, neuroserpin
formed SDS-stable complexes and inhibited the amidolytic
activity of tissue plasminogen activator, urokinase, and plasmin.
In contrast, no complex formation with or inhibition of thrombin
was found. Expression pattern and inhibitory specificity impli-
cate neuroserpin as a candidate regulator of plasminogen ac-
tivators, which have been suggested to participate in the mod-
ulation or reorganization of synaptic connections in the adult.
During development, neuroserpin may attenuate extracellular
proteolysis related to processes such as neuronal migration,
axogenesis, or the formation of mature synaptic connections.
Key words: neuroserpin; serine protease inhibitor; plasmino-
gen activator; plasmin; thrombin; central nervous system; syn-
aptogenesis; neuronal plasticity
Serine proteases have been implicated in a variety of processes
during nervous system development. Thrombin is known to in-
hibit and reverse neurite outgrowth in cell culture (Gurwitz and
Cunningham, 1988) and may participate in activity-dependent
synapse elimination at the neuromuscular junction (Liu et al.,
1994). Plasminogen activators (PAs), secreted from growth cones
of extending neurites (Krystosek and Seeds, 1981, 1984), modu-
late neurite outgrowth in vitro (Pittman et al., 1989; Pittman and
DiBenedetto, 1995), and may also facilitate neuronal migration
(Moonen et al., 1982; Friedman and Seeds, 1995). Recently, a
function of PAs in synaptic plasticity and memory formation has
been suggested. Tissue plasminogen activator (tPA) mRNA levels
are increased in the hippocampus on induction of long-term
potentiation (LTP) (Qian et al., 1993) and in the cerebellum after
learning of a complex motor task (Seeds et al., 1995). In line with
these observations, it has been reported that the release of tPA
from PC12 cells is dependent on membrane depolarization and
calcium influx (Gualandris et al., 1996). Moreover, mice deficient
in tPA exhibit an interference in long-lasting LTP (Frey et al.,
1996; Huang et al., 1996) and show an impaired performance in
a two-way active avoidance learning paradigm (Huang et al.,
1996). On the other hand, mice overexpressing urokinase (UPA)
in neocortex, hippocampus, and amygdala perform poorly in tasks
of spatial, olfactory, and taste aversion learning (Meiri et al.,
1994).
Serine proteases with a role in the nervous system may be
regulated by serine protease inhibitors in a manner analogous to
the serine proteases involved in blood coagulation, fibrinolysis, or
remodeling of non-neural tissues. One major class of inhibitors
comprises structurally homologous proteins, termed serpins,
which exert their inhibitory activity by forming stable complexes
with their target proteases (for review, see Schapira and Patson,
1991; Potempa et al., 1994). A well characterized neurally ex-
pressed serpin is protease nexin-1 (PN-1). Initially described as a
glia-derived serpin, it is also expressed by subsets of neurons
(Mansuy et al., 1993). PN-1 has a neurite outgrowth-promoting
effect on neuroblastoma cells and sympathetic neurons in vitro
(Guenther et al., 1985; Gloor et al., 1986) that depends on its
inhibitory activity toward thrombin (Gurwitz and Cunningham,
1990). We have recently identified neuroserpin, a novel serpin
(Osterwalder et al., 1996), that had originally been characterized
as a protein secreted from neurites of chicken embryonic dorsal
root ganglion (DRG) neurons (Stoeckli et al., 1989). An analysis
of its primary structure suggested that neuroserpin is an inhibitor
of trypsin-like serine proteases such as thrombin and PAs. We
have now isolated the cDNA of the murine homolog of neuro-
serpin and analyzed its spatio-temporal expression in the mouse
nervous system to obtain an indication about its functional role in
the developing and the adult nervous systems. To investigate the
inhibitory activity and specificity of neuroserpin, we performed
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complex formation and inhibition assays with the purified recom-
binant protein and several neurally expressed serine proteases.
MATERIALS AND METHODS
cDNA cloning and sequencing. Total RNA from brains of postnatal day 10
(P10) mice was isolated as described by Chomczynski and Sacchi (1987).
cDNA was prepared using SuperScript RNase H reverse transcriptase
(Life Technologies, Gaithersburg, MD) as recommended by the manu-
facturer. PCR was performed with Taq polymerase (Perkin-Elmer,
Branchburg, NJ) according to the supplier’s recommendations. A first
amplification (35 cycles, 1 min at 93°C, 1 min at 50°C, and 2 min at 70°C)
was performed with the degenerate primers 59-GCI ATI TAY TTY
AAR GGI AAY TGG AA-39 (sense; I 5 inosine; R 5 A or G, and Y 5
T or C) and 59-CC CAT RAA IAR IAC IGT ICC NGT-39 (antisense;
N 5 A, G, C, or T); a fraction of the reaction products was reamplified
(35 cycles, 1 min at 93°C, 1 min at 55°C, and 2 min at 72°C) with the
oligonucleotides 59-ggg gga tcc GAR ACI GAR GTI CAR ATI CCI
ATG ATG-39 (sense) and 59-ggg gatc cGG RTG RTC IAC IAT IAC
YTG NGG-39 (antisense). The amplified 420 bp cDNA fragment of
mouse neuroserpin was labeled with [a-32P]dCTP by random priming
(random priming kit from Stratagene, La Jolla, CA). The labeled probe
was used to screen ;2 3 10 6 phage plaques of an oligo(dT)-primed P20
mouse brain cDNA library (Stratagene, catalog #937319) as described by
Sambrook et al. (1989). DNA of positive phage clones was isolated and
subjected to restriction analysis. The cDNA of one of the clones with the
longest cDNA insert was selected for sequencing of both strands. Se-
quence assembly and comparison were performed using computer pro-
grams of the Genetics Computer Group (Madison, WI) package.
Synthesis of riboprobes for Northern and in situ hybridization. As tem-
plate for riboprobe synthesis, the full-length cDNA of mouse neuroser-
pin or fragments of it [nucleotides (nt) 1–365, 464–788, 788–1211, and
2037–2395] in the phagemid vector pBluescript (Stratagene) were linear-
ized with restriction enzymes cutting immediately downstream of the
cDNA to be transcribed. Using T3 or T7 RNA polymerase and a
ribonucleotide mix containing digoxigenin-labeled uridine triphosphate
(Boehringer Mannheim, Mannheim, Germany), cRNA was transcribed
according to the manufacturer’s recommendations. For in situ hybridiza-
tion with riboprobes transcribed from the full-length cDNA, the cRNA
was subjected to limited alkaline hydrolysis in 100 mM sodium carbonate,
pH 10.2, at 60°C for 40 min. The integrity of the riboprobes was
controlled by agarose gel electrophoresis, and their approximate concen-
tration was estimated.
Northern blot analysis. Total RNA was isolated from various tissues of
adult mice of strain ICR by acid guanidinium thiocyanate–phenol–
chloroform extraction (Chomczynski and Sacchi, 1987). Samples of 15 mg
of total RNA were separated on a formaldehyde-containing agarose gel,
transferred to a nylon membrane, and immobilized as described by
Sambrook et al. (1989). After prehybridization in hybridization buffer
containing 53 SSC, 50% formamide, 0.02% SDS, 0.1% N-
lauroylsarcosine, and 2% (w/v) blocking reagent (Boehringer Mann-
heim), membranes were incubated overnight with ;20 ng/ml
digoxigenin-labeled RNA in hybridization buffer at 68°C. Membranes
were washed in 23 SSC/0.1% SDS and 0.13 SSC/0.1% SDS at 68°C and
incubated with an alkaline phosphatase (AP)-conjugated anti-
digoxigenin antibody (Boehringer Mannheim). The washed membranes
were then incubated with the chemiluminescent AP substrate CDP-Star
(Boehringer Mannheim) according to the supplier’s recommendations
and exposed to x-ray film.
In situ hybridization. In situ hybridization was performed essentially as
described by Schaeren-Wiemers and Gerfin-Moser (1993). Briefly, tissues
were quickly removed from ICR mice killed by asphyxiation with CO2
and immediately frozen in a bed of pulverized dry ice. To obtain mouse
embryos of determined gestational age, the onset of pregnancy was
determined by the appearance of a vaginal plug and counted as embry-
onic day 0 (E0). Embryos were checked for correct gestational age using
the criteria established by Theiler (1989). For postnatal mice, the day of
birth was taken as P0. Cryosections were cut at 12–20 mm and thaw-
mounted on poly-L-lysine-coated slides, fixed in PBS containing 4%
paraformaldehyde, and acetylated with acetic anhydride. After prehy-
bridization in hybridization buffer containing 53 SSC, 50% formamide,
53 Denhardt’s solution, 250 mg/ml total yeast RNA, and 500 mg/ml DNA
from herring sperm, hybridization was performed at 55°C overnight
using ;0.25 mg/ml digoxigenin-labeled riboprobes diluted in hybridiza-
tion buffer. Sections were then subjected to low-stringency (23 SSC) and
high-stringency (0.13 SSC/50% formamide at 55°C) washes. Hybridized
riboprobe was detected using an AP-coupled anti-digoxigenin antibody
(Boehringer Mannheim) and the AP substrates nitrotetrazolium blue
and X-phosphate (Boehringer Mannheim). As a control for the specific-
ity of the labeling, in each hybridization experiment sections adjacent to
those hybridized with the antisense neuroserpin cRNA were incubated
with an equal concentration of a sense riboprobe transcribed from the
same template. Control sections showed no staining except for strong
labeling in the intestinal mucosa of embryos older than E15, which was
probably caused by endogeneous intestinal AP. In addition, we have
performed in situ hybridization with four different antisense riboprobes
from nonoverlapping regions of the mouse neuroserpin cDNA (nt 1–365,
464–788, 788–1211, and 2037–2395). The staining obtained with these
riboprobes was qualitatively identical to that obtained with the antisense
riboprobe transcribed from the full-length cDNA, which was chosen for
hybridization of all sections shown in the figures.
Detection of neuroserpin in tissue extracts. For detection of neuroserpin
protein in tissue extracts, neuroserpin was immunoprecipitated with the
monoclonal antibody A15F2 raised against neuroserpin. The immuno-
precipitate was subjected to SDS-PAGE and blotted onto nitrocellulose,
and neuroserpin was detected with rabbit anti-neuroserpin antiserum.
The monoclonal antibody A15F2 was obtained by immunization of a rat
with recombinant mouse neuroserpin and subsequent fusion of splenic B
cells with the mouse myeloma cell line Ag8-653. Fusion and subsequent
selection of myeloma clones were essentially performed as described by
Fazekas de St. Groth and Scheidegger (1980). The antiserum R61 was
raised by immunization of a rabbit with recombinant chicken neuroser-
pin. Tissue extracts were prepared as follows. Tissues were quickly
removed from killed animals and homogenized in a buffer (1 ml/100 mg
of tissue) containing 140 mM NaCl, 10 mM Tris-Cl, pH 8.0, 1% (v/v)
Triton X-100, 2 mg/ml aprotinin, 1 mM iodacetamide, and 1 mM PMSF.
Tissue extracts were cleared from insoluble material by ultracentrifuga-
tion and preincubated with Sepharose 4B (Pharmacia, Uppsala, Sweden)
for at least 3 hr at 4°C. For immunoprecipitation, the monoclonal anti-
body A15F2 was purified from conditioned media by protein G chroma-
tography and coupled to cyanogen bromide-activated Sepharose (A15F2-
S4B) at a concentration of 5 mg/ml of resin. Neuroserpin was
immunoprecipitated from extracts by addition of 25 ml of A15F2-S4B/ml
of extract and subsequent incubation of the suspension for 3 hr at 4°C on
an end-over-end shaker. The A15F2-S4B slurry was washed extensively
with a buffer containing 140 mM NaCl, 10 mM Tris-Cl, pH 8.0, 0.1% (v/v)
Triton X-100, and, in a last washing step, 50 mM Tris-Cl, pH 6.8.
Neuroserpin was eluted by boiling the affinity resin for 10 min in 15%
(v/v) glycerol, 3% (w/v) SDS, 60 mM Tris-Cl, pH 6.8, and 0.01% (w/v)
bromphenol blue. After removal of the resin, b-Mercaptoethanol was
added to the eluates to a concentration of 5% (v/v). Samples were again
boiled for 3 min, subjected to SDS-PAGE, and blotted to nitrocellulose.
Immunodetection with affinity-purified R61 antiserum, horseradish
peroxidase-coupled anti-rabbit IgG polyclonal antibody, and chemilumi-
nescent visualization was performed as recommended by the supplier of
the chemiluminescence blotting kit (Boehringer Mannheim).
Heterologous expression and purification of recombinant mouse neuro-
serpin. Mouse neuroserpin was cytoplasmically expressed in Escherichia
coli with a stretch of six histidines fused to the C terminus of the protein.
Briefly, a fragment of mouse neuroserpin cDNA encoding amino acids
17–410 of mouse neuroserpin was amplified in a PCR using the oligode-
oxynucleotides 59-GC TCT AGA CAT ATG ACA GGG GCA ACG
TTC CCA-39 and 59-GGG AAG CTT CTA GTG GTG ATG GTG GTG
GTG AAG TTC CTC AAA GTC ATG GC-39 as primers. Integrity of
the amplified sequence was confirmed by DNA sequencing. The cDNA
fragment was cloned into the vector pAK400 (Krebber et al., 1997) via
the NdeI and HindIII sites of the vector, allowing expression of the cDNA
from the lac operator/promoter located immediately upstream. For ex-
pression, a colony of E. coli strain DH5a harboring the expression
plasmid was precultured overnight at 25°C in 10 ml of Luria-Bertani
medium (LB) containing 25 mg/ml chloramphenicol. One liter of LB
containing 25 mg/ml chloramphenicol was inoculated with the preculture,
grown in a shaking water bath at 25°C, and induced with 1 mM isopropyl-
1-thio-b-D-galactopyranoside at an OD600 of 0.5. Bacteria were harvested
by centrifugation 5 hr after induction, resuspended in loading buffer (1 M
NaCl and 50 mM Tris-Cl, pH 8.0), and disrupted in a French press. The
soluble protein extract was cleared from debris by centrifugation and
loaded onto Ni-nitrilo-triacetate resin (Qiagen, Chatsworth, CA). After
extensive washing with loading buffer, proteins adhering to the metal
chelate resin were eluted with loading buffer containing 200 mM imida-
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zole. The eluted protein was dialyzed against 150 mM NaCl and 10 mM
sodium phosphate, pH 7.0, and stored at 280°C.
Complex formation assay. Recombinant neuroserpin at a concentration
of 1 mM was incubated with recombinant human tPA (Genentech, South
San Francisco, CA), uPA, plasmin, or thrombin (Sigma, St. Louis, MO)
at a concentration of 0.3 or 1 mM in 150 mM NaCl and 10 mM sodium
phosphate, pH 7.0, for 10 min on ice. Ten microliters of the samples were
mixed with an equal volume of SDS-PAGE loading buffer [30% (v/v)
glycerol, 10% (v/v) b-mercaptoethanol, 6% (w/v) SDS, 125 mM Tris-Cl
pH 6.8, and 0.01% (w/v) bromphenol blue] and subjected to SDS-PAGE.
Neuroserpin and neuroserpin-containing protein complexes were de-
tected by immunoblotting as described above using the antiserum R61.
Inhibition of protease amidolytic activity. tPA, uPA, plasmin, or throm-
bin at a concentration of 8 nM and recombinant neuroserpin at a con-
centration of 26.7, 80, 267, or 800 nM were preincubated for 5 min at 25°C
in amidolytic assay buffer [137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 ,
1.4 mM KH2PO4 , 0.2% (w/v) BSA, and 0.1% (w/v) polyethylene glycol
8000]. The broad-spectrum chromogenic protease substrate H-D-
isoleucyl-L-prolyl-L-arginine-p-nitroaniline-dihydrochloride (Chromoge-
nix, Mo¨lndal, Sweden) was then added to a concentration of 1 mM.
Samples were further incubated at 25°C, and the velocities of amidolytic
liberation of p-nitroaniline were determined by measuring the absor-
bance at 405 nm at different times of the reaction.
RESULTS
Cloning and characterization of the cDNA of
mouse neuroserpin
The cDNA of mouse neuroserpin was isolated by nested PCR
using cDNA derived from total brain RNA and degenerate oli-
gonucleotide primers designed on the basis of the chicken neu-
roserpin cDNA sequence (Osterwalder et al., 1996). The ampli-
fied 420 bp cDNA fragment was subsequently used to screen an
oligo-dT-primed postnatal mouse brain cDNA library. All posi-
Figure 1. Nucleotide and deduced amino acid sequence of mouse neuroserpin (EMBL and GenBank accession number AJ001700). Amino acids
conserved between mouse, human, and chicken neuroserpin are printed in bold. The stop codons flanking the single large open reading frame are marked
by asterisks. The putative preprotein sequence determined according to von Heijne (1983) is underlined, and putative N-glycosylation sites are
emphasized with circles. The putative reactive site loop is marked by a broken line, and the residues flanking the putative reactive site are indicated
according to the nomenclature of Schechter and Berger (1967) with P1 and P19. The 39 untranslated region contains two polyadenylation signals (boxed).
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tive clones isolated and subjected to restriction analysis contained
the same cDNA, either in full length of 2.9 kb or fragments
thereof. The cDNA obtained comprised a single long ORF en-
coding a protein of 410 amino acids (Fig. 1). The nucleotide
sequence adjacent to the putative start codon matches the con-
sensus described by Kozak (1987). A segment of 16 amino acids
after the putative translation start is rich in hydrophobic residues
and conforms to the characteristics of signal peptides (von Heijne,
1985). The deduced amino acid sequence exhibits an identity of
76% to chicken neuroserpin and 86% to the recently character-
ized human neuroserpin (Schrimpf et al., 1997). Interestingly, the
reactive site loop, a peptide segment close to the C terminus that
interacts with the active site of the cognate protease, is fully
conserved between chicken and mouse neuroserpin and shows
only one conservative amino acid exchange (Ala-345 to Val) in
the human species homolog. Of other known mouse serpins, PN-1
(36% amino acid identity), antithrombin-III (34%), and plasmin-
ogen activator inhibitor-1 (33%) display the strongest sequence
similarity to neuroserpin.
Localization of neuroserpin expression in the adult
mouse CNS
The tissue distribution of neuroserpin mRNA in the adult mouse
was investigated by Northern blot analysis. Two neuroserpin
transcripts of ;3.0 and 1.6 kb were present in the brain and, in
considerably smaller quantities, in the spinal cord, heart, kidney,
and testis. No neuroserpin mRNA was detected in the intestine,
liver, lung, skeletal muscle, spleen, and thymus (Fig. 2). The size
of the two neuroserpin mRNA species may be attributed to the
alternative usage of the two polyadenylation signals found at nt
1551–1556 and 2905–2910, respectively (Fig. 1).
The distribution of neuroserpin mRNA in the adult mouse
brain was analyzed by in situ hybridization of coronal and hori-
zontal brain sections (Fig. 3, Table 1). Restriction of the hybrid-
ization signals to gray matter, the size and morphology of the
cells stained, and the clear delineation of the hybridization signals
along the boundaries of nuclei and laminae indicated that neuro-
serpin in the adult brain is expressed predominantly by neurons.
The most prominent expression of neuroserpin was observed in
the olfactory bulb, the isocortex, the hippocampal formation, and
the amygdala. In contrast, no neuroserpin transcript could be
detected in the caudate putamen and in most thalamic nuclei,
including all sensory relay nuclei. Neuroserpin mRNA expression
was also observed in many midbrain, pontine, and medullary
regions, including the superior and inferior colliculus, all motor
and sensory cranial nerve nuclei, and components of the reticular
formation. In the cerebellum, neurons of the deep nuclei, cells in
the molecular layer, possibly basket and stellate neurons, and a
few scattered cells in the granule cell layer expressed neuroserpin
mRNA at moderate concentrations (see Figs. 3H,J, 6H). In con-
trast, no expression was observed in granule cells or the cerebellar
white matter. Moderately stained cells within or closely associ-
ated with the Purkinje cell layer but with cell bodies too small to
account for Purkinje cells may resemble basket neurons or Golgi
epithelial cells (see Fig. 6H). Most Purkinje cells appeared to be
devoid of detectable neuroserpin expression. However, among
the more numerous moderately positive smaller cells a few large,
pear-shaped, weakly labeled neurons were observed, which may
represent a subpopulation of Purkinje cells expressing low
amounts of neuroserpin. In the spinal cord, cells with low to
moderate neuroserpin expression were found in the ventral horn,
the intermediate zone, and the ventral laminae of the dorsal horn
(see Fig. 7G). It is noteworthy that neither the neuroserpin-
positive populations of CNS neurons nor those that do not
express neuroserpin mRNA can be assigned to a distinct neuronal
category. Both local inhibitory (e.g., cerebellar basket and stellate
cells and hippocampal interneurons) and excitatory projection
neurons (e.g., pyramidal neurons of the hippocampus and spinal
cord motoneurons) express neuroserpin. Likewise, many neurons
with modulatory actions, such as noradregenic neurons of the
locus coeruleus and serotonergic neurons of the raphe nuclei, are
strongly positive for neuroserpin.
Spatio-temporal pattern of neuroserpin expression in
the developing nervous system
During embryonic development, neuroserpin was predominantly
expressed in the nervous system (Fig. 4). Only at very early
embryonic stages (E14 and earlier) were faint hybridization sig-
nals also observed in the liver. In the PNS, DRGs, cranial nerve
ganglia, both sympathetic and parasympathetic ganglia, and the
olfactory epithelium expressed neuroserpin. In DRG neurons
neuroserpin mRNA was observed as early as E10, and expression
reached maximal levels perinatally and remained high in the
adult (see Fig. 7).
Most CNS regions expressed neuroserpin during embryonic
development. No expression of neuroserpin was found in periven-
tricular neuroepithelia. Subventricular zones in most CNS re-
gions, however, were positive for neuroserpin mRNA immedi-
ately at their appearance (Fig. 4A), suggesting that most CNS
neurons start to express neuroserpin when they become postmi-
totic and migrate away from the ventricular zone. Neuroserpin
mRNA was initially expressed rather homogeneously in low
amounts throughout most CNS differentiating fields but showed a
more differential distribution at later stages (E15 and older) with
Figure 2. Distribution of neuroserpin mRNA in adult mouse tissues. Ten
micrograms each of total RNA from various tissues were separated by
agarose gel electrophoresis and blotted onto a nylon membrane, which
was subsequently incubated with a neuroserpin antisense cRNA probe
(top) or, to assess integrity of RNA, with a glyceraldehyde-3-phosphate
dehydrogenase antisense riboprobe. Two neuroserpin transcripts of 1.6
and 3.0 kb, respectively, were detected in brain and, in lower quantities, in
spinal cord and heart. Testis and kidney RNA contained only the small
transcript in very low amounts.
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Figure 3. Neuroserpin expression in the adult mouse brain. In situ hybridization of horizontal (A, B) and coronal brain sections (E–K ) with an antisense
(A, D–K ) or sense riboprobe ( B) transcribed from the mouse neuroserpin cDNA. C, D, Consecutive coronal sections of the parietal cortex stained either
with cresyl violet (C) or with antisense neuroserpin mRNA (D). 3, 7, 10, 12, Nuclei of the respective cranial nerves; I, II/III, IV, V, VI, isocortical layers;
bl, basolateral nucleus of the amygdala; ca1, ca3, hippocampal fields; co, cochlear nuclei; cpu, caudate putamen; dcn, deep cerebellar nuclei; dlg, dorsal
lateral geniculate nucleus; dg, dentate gyrus; gi, gigantocellular reticular nucleus; io, inferior olive; la, lateral nucleus of the amygdala; lc, locus coeruleus;
r, red nucleus; rt, reticular thalamic nucleus; sn, substantia nigra; sol, solitary nucleus; sp5, spinal trigeminal nucleus; vnc, vestibular nuclear group; vp,
ventroposterior thalamic nucleus. Scale bars: A, B, E–K, 500 mm; D, 100 mm.
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highest levels of expression in the neocortex, the hippocampus,
the cerebellar primordium, pons, and medulla (Fig. 4B,C).
In the neocortex, neuroserpin expression was observed in the
emerging intermediate zone at E13 and increased at E15 (Fig.
4B). At E17, neuroserpin mRNA was detected in high amounts in
the infragranular part of the cortical plate and in the subplate and
in lower amounts in the supragranular part of the cortical plate
and in the intermediate zone (Fig. 4E). During postnatal devel-
opment, levels of expression in all neocortical layers still in-
creased to reach adult levels of expression during the second
postnatal week.
Transient expression of neuroserpin during embryonic and
Table 1. Distribution of neuroserpin mRNA in adult mouse brain
Isocortex Septum Pretectal nu group 11
Layer I 0/11a Medial septal nu 1
Layer II–III 11/111 Nu diagonal band (Broca) 1 Superior colliculus 1/11
Layer IV 0/111b Lateral septal nu 0
Layer V 111 Inferior colliculus 1
Layer VI 1/111 Hypothalamus
Periventricular preoptic nu 1 Central gray 1/11
Cingulate cortex 111 Medial preoptic nu 1 Dorsal tegmental nu 111
Piriform cortex 111 Magnocellular preoptic nu 11
Entorhinal cortex (s. II–VI) 111 Suprachiasmatic nu 0 Cranial nerve nuclei
Paraventricular nu 11 Oculomotor nu 11
Subiculum (s. pyramidale) 111 Anterior hypothalamic nu 1 Trochlear nu 11
Supraoptic nu 11 Motor trigeminal nu 11
Hippocampus Arcuate nu 1 Principal sensory trigem. nu 11
S. pyramidale, CA1 111 Ventromedial nu 1 Abducens nu 11
S. pyramidale, CA2/3 1/111c Dorsomedial nu 1 Facial nu 11
CA4 111 Tuberal nu 1 Vestibular nu group 11
Dentate granule cell layer 1/111a Medial mammillary nu Cochlear nu group 11
S. oriens 111c Medial subnucleus 111 Dorsal motor nu of vagus 111
S. lucidum 111c Lateral subnucleus 0 Hypoglossal nu 11
S. radiatum 111c Lateral mammillary nu 1 Nu of the solitary tract 11
S. moleculare/ lacunosum mol. 0
Epithalamus Red nu 11
Olfactory bulb Medial habenular nu 1
Olfactory nerve layer 0 Lateral habenular nu 0 Pontine nuclei 0
Glomerular layer 0/11 Reticulotegmental nu pons 11
Mitral cell layer 111 Thalamus dorsalis Lateral reticular nu 11
Internal plexiform layer 11 Anterodorsal nu 1 Inferior olive 1/11
Granular layer 11 Anteroventral nu 0
Anteromedial nu 0 Cerebellum
Amygdala Mediodorsal nu 0 Molecular layer 11d
Olfactory amygdala 11 Laterodorsal nu 0 Purkinje cell layer 0/11e
Medial amygdala 11 Lateroposterior nu 0 Granule cell layer 0/11f
Basolateral amygdala 111 Posterior nu group 0 Deep cerebellar nuclei 11
Central amygdaloid nu 1 Paraventricular nu 11
Reuniens nu 111 Locus coeruleus 111
Basal ganglia Centromedial nu 1
Accumbens nu 0 Parafascicular nu 1 Superior olivary complex 1
Caudate putamen 0 Ventromedial nu 0
Globus pallidus 0/1a Ventrolateral nu 0 Dorsal raphe nu 11
Entopeduncular nu 0 Ventroposterior nu 0 Raphe pontis nu 1
Subthalamic nu 111 Medial geniculate nu 0 Gigantocellular reticular nu 11
Substantia nigra Lateral geniculate nu Medullary reticular field 11
Pars reticulata 1 Dorsal subdivision 0
Pars compacta 1 Ventral subdivision 1 Gracilis nu 1
Reticular nu 111 Cuneate nu 1
nu, Nucleus; s, stratum; 0, no; 1, low; 11, moderate; 111, strong neuroserpin expression.
a Very few cells positive for neuroserpin mRNA.
b Granule cells of layer IV not stained; some large, strongly expressing cells.
c Scattered strongly positive cells; distribution reminiscent of interneurons.
d Neuroserpin-positive cells likely represent stellate and basket interneurons as judged by number and morphology of labeled cells.
e Most Purkinje cells devoid of neuroserpin mRNA (see Results).
f Very low number of positive cells, possibly Golgi neurons.
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early postnatal development was observed in the thalamus (Fig.
5). Beginning at E13, i.e., before thalamic neuronal precursors
have begun to extend neurites (Lund and Mustari, 1977; Altman
and Bayer, 1989), and continuing throughout embryonic develop-
ment, low amounts of neuroserpin mRNA were distributed rather
homogeneously throughout the anterior and posterior thalamic
differentiating fields. No neuroserpin expression, however, could
be detected in the differentiating field of the reticular nucleus. In
the reticular nucleus neuroserpin expression, first observed at P2,
increased rapidly during postnatal development (Fig. 5B,C). In
contrast, expression in the ventrolateral–ventromedial nuclear
complex and in most thalamic association nuclei rapidly declined
at approximately P4 (Fig. 5B). Likewise, neuroserpin mRNA
disappeared from the sensory relay nuclei between P6 and P8
(Fig. 5E,F).
In the differentiating field of the cerebellar primordium, neu-
roserpin mRNA was detected in low quantities at E13 (not
shown). In 15-d-old embryos, neuroserpin was expressed in low
amounts both in the nuclear transitory zone, giving rise to the
deep cerebellar nuclei (Altman and Bayer, 1985a), and in the
cortical transitory zone (Fig. 6A). Between E17 and E19 clusters
of cells that express neuroserpin very strongly became apparent in
the differentiating fields of the cerebellar hemispheres (Fig. 6B).
These cells may represent Purkinje cells migrating radially from
the lateral cerebellar primordium to a superficial position beneath
the external germinal layer (EGL) of the cerebellar hemispheres
(Altman and Bayer, 1985b). In contrast, the already settled Pur-
kinje cells of the posterior vermis expressed no or very small
amounts of neuroserpin. In the postnatal mouse cerebellum,
strong expression of neuroserpin was observed in patches of
Purkinje cells that appeared to be confined to parts of the cere-
bellar hemispheres and the lateral vermis (Fig. 6C–E); the
amount of neuroserpin mRNA in these Purkinje cell clusters
sharply declined between P8 and P12. Purkinje cells of the cere-
bellar hemispheres outside these strongly expressing clusters con-
tained only intermediate amounts of neuroserpin mRNA,
whereas Purkinje cells of the medial vermis expressed no detect-
able quantities of neuroserpin during this developmental period.
The EGL, devoid of neuroserpin mRNA during embryonic de-
velopment, became positive for neuroserpin mRNA at approxi-
mately P2. Whereas premigratory granule cells in the EGL ex-
pressed only low amounts of transcript, higher levels of
neuroserpin mRNA were observed in postmigratory granule cells
in the internal granular layer during the first 2 postnatal weeks
(Fig. 6F,G); expression in granule cells decreased to undetectable
levels after the third postnatal week (Fig. 6H). Neuroserpin-
positive cells in the molecular layer were first observed at approx-
imately P12. Expression in these cells, probably stellate and/or
basket interneurons, increased to reach adult levels by P20.
In the spinal cord, neuroserpin expression was observed as
early as at E10 (Fig. 7B). In the mantle layer of the spinal cord
both in the alar plate and in the basal plate, differentiating
neurons expressed low amounts of neuroserpin, whereas the
ventricular zone, roof plate, and floor plate were devoid of
neuroserpin-expressing cells. At this stage, motoneurons in the
basal plate (Wentworth, 1984a) and association neurons in the
alar plate have just begun to differentiate, and axons of many
commissural neurons cross the floor plate (Wentworth, 1984b). In
13-d-old embryos, the number of neuroserpin-expressing cells
both in the alar and in the the basal plate had increased consid-
erably (Fig. 7C) and by E15 only the now relatively small ventric-
ular zone, the floor plate, and the fiber tracts were devoid of
neuroserpin-positive cells (Fig. 7D). In all spinal cord regions, the
level of neuroserpin expression increased steadily and reached
maximal levels perinatally (Fig. 7E); thereafter, it decreased in all
laminae. Whereas motoneurons reached their moderate adult
expression levels by P6, and cells in the substantia gelatinosa
ceased neuroserpin expression by this time (Fig. 7F), expression
Figure 4. Distribution of neuroserpin mRNA in the developing mouse. Parasagittal sections of E13 (A), E15 (B), and E17 (C, D) mouse embryos
hybridized with a neuroserpin antisense (A–C ) or sense (D) riboprobe. 5g, 8g, 10g, Ganglia of fifth, eighth, and 10th cranial nerves, respectively; ce,
cerebellar primordium; drg, dorsal root ganglia; h, hypothalamus; hc, hippocampus; in, intestine; li, liver; md, medulla; nc, neocortex; ob, olfactory bulb;
oe, olfactory epithelium; po, pons; te, tectum; th, thalamus. Note that staining in the intestinal mucosa in sections from E17 mice results from the presence
of tissue-derived intestinal alkaline phosphatase. Cells scattered between intestinal muscle layers, however, are specifically stained in antisense sections
and may represent plexus of the autonomous nervous system. E, Enlargement of a region of the E17 neocortex (boxed in C). mol, Molecular layer; cpi
infragranular part of cortical plate; cps, supragranular part of the cortical plate; sp, subplate; iz, intermediate zone; vz, ventricular zone. Scale bars: A–C,
500 mm; D, 1 mm.
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in neurons of the intermediate zone and the ventral laminae of
the dorsal horn declined more slowly to reach intermediate adult
quantities by the third postnatal week (Fig. 7G).
Spatio-temporal distribution of neuroserpin protein
We also investigated the distribution of neuroserpin protein both
in various non-neuronal tissues and in the CNS. Because we were
not able to detect neuroserpin by immunohistochemistry or in
tissue extracts directly by immunoblot analysis, we immunopre-
cipitated neuroserpin from extracts using a rat monoclonal anti-
body directed against mouse neuroserpin and subjected precipi-
tated protein to immunoblotting using an antiserum against
neuroserpin raised in rabbit. In the adult mouse, neuroserpin
protein was detected in the brain and spinal cord, and, in lower
amounts, in testis (Fig. 8A) In most tissues, this distribution
closely reflects the occurrence of neuroserpin mRNA as observed
by Northern blot (Fig. 2). The failure to detect neuroserpin
protein in heart and kidney, tissues shown to contain small
amounts of neuroserpin mRNA, may be attributable to tissue-
specific differences in the regulation of posttranscriptional pro-
cesses or protein turnover. In the adult murine brain, neuroserpin
was detected in the neocortex, hippocampus, olfactory bulb, and,
in smaller quantities, in striatum, thalamus, and cerebellum (Fig.
8B). The occurrence of significant amounts of neuroserpin pro-
tein in striatum and thalamus, brain regions in which only small
subpopulations of neurons express neuroserpin mRNA, may be
indicative for an axonal transport of the protein, complementing
data on axonal transport and secretion of neuroserpin in primary
neuronal cultures (Stoeckli et al., 1989; Osterwalder et al., 1996).
In total brain extracts of different developmental stages, the
amount of neuroserpin protein was found to increase between
E14 and E17, to reach a maximum perinatally, and to decline
slowly thereafter to an intermediate level in the adult (Fig. 8C),
arguing in favor of a function of the protein during late embry-
onic or postnatal development of the nervous system or its main-
tenance in the adult.
Inhibition of plasminogen activators and plasmin, but
not of thrombin, by recombinant neuroserpin in vitro
The majority of proteins belonging to the structurally defined
family of serpins are inhibitors of serine proteases, yet some
serpins such as ovalbumin, angiotensinogen, and the thyroxine-
and corticosteroid-binding globulins do not exhibit inhibitory
activity. Inhibitory serpins act as substrate mimics, forming stable
stoichiometric complexes with their cognate proteases. By se-
quence comparison with other serpins, neuroserpin was predicted
to be an inhibitory serpin directed against trypsin-like proteases
(Osterwalder et al., 1996). To test this hypothesis and to deter-
mine the inhibitory specificity, we have heterologously expressed
neuroserpin fused C-terminally to a stretch of six histidines in E.
Figure 5. Neuroserpin expression in the developing thalamus. Coronal sections of the anterior (A–C ) or posterior (D–F ) thalamus of E18 (A), P0 (D),
P4 (B), P8 (E), or P12 (C, F ) mice; in situ hybridization using an antisense neuroserpin riboprobe. Cm, Centromedial nucleus; dlg, dorsal lateral
geniculate nucleus; ld, laterodorsal nucleus; md, mediodorsal nucleus; pv, paraventricular nucleus; re, reuniens nucleus; rt, reticularis nucleus; vl,
ventrolateral nucleus; vlg, ventral lateral geniculate nucleus; vp, ventroposterior nucleus. Scale bars: A, D, 200 mm; B, C, E, F, 400 mm.
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coli and purified the recombinant protein by metal chelate affinity
chromatography (Fig. 9A). The inhibitory activity of recombinant
mouse neuroserpin toward tPA, urokinase, plasmin, and throm-
bin, neurally expressed serine proteases (Dihanich et al., 1991;
Dent et al., 1993; Sappino et al., 1993; Tsirka et al., 1997), was
assessed. For this purpose, we tested the ability of neuroserpin to
form stable complexes with these proteases, taking advantage of
the fact that serine protease–serpin complexes are stable during
SDS-PAGE. When recombinant neuroserpin was incubated
with tPA, and the sample was analyzed by SDS-PAGE followed
by immunoblotting with an antiserum against neuroserpin, two
protein complexes were observed (Fig. 9B). These immunore-
active protein complexes had apparent molecular weights that
corresponded to the sum of the molecular weights of neuro-
serpin and single-chain tPA or the protease domain of two-
chain tPA, respectively. Similarly, when recombinant neuro-
serpin was incubated with urokinase or plasmin, protein
complexes with apparent molecular weights corresponding to
the sum of the molecular weights of neuroserpin and urokinase
or plasmin, respectively, were detected. In contrast, no protein
complexes containing neuroserpin were formed when recom-
binant neuroserpin was incubated with thrombin. In a second
set of experiments, we tested the ability of recombinant neu-
roserpin to inhibit the amidolytic activity of tPA, urokinase,
Figure 6. Detection of neuroserpin mRNA in the developing cerebellum. Coronal sections of the cerebellar primordium or cerebellum at E15 (A),
E16.5 (B), P0 (C), P4 (D), and P8 (E); higher magnification of the fifth cerebellar lobule sectioned coronally at P8 (F ), P12 (G), and P28 (H ). The latter
developmental stage closely resembles neuroserpin mRNA staining in the adult cerebellum. Arrowheads in B–E denote patches of Purkinje cells strongly
positive for neuroserpin. IV, Fourth ventricle; aq, aqueduct; ctz, cortical transition zone; dcn, deep cerebellar nuclei; egl, external germinal layer; igl, inner
granular layer; mol, molecular layer; ne, neuroepithelum; ntz, nuclear transition zone; pu, Purkinje cell layer. Scale bars: A–E, 200 mm; F–H, 25 mm.
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plasmin, and thrombin on the broad-spectrum chromogenic
serine protease substrate D-isoleucyl-L-prolyl-L-arginine-p-
nitroaniline. Recombinant neuroserpin inhibited the amidol-
ytic activity of tPA and, to a smaller extent, uPA and plasmin,
but it failed to inhibit thrombin (Fig. 9C). Essentially the same
results concerning complexation and inhibition of serine pro-
teases have been obtained with recombinant chicken neuroser-
pin (T. Osterwalder, P. Cinelli, A. Baici, A. Pennella, S. R.
Krueger, S. P. Schrimpf, M. Meins, and P. Sonderegger, un-
published observations).
DISCUSSION
Neuroserpin is expressed during neuronal migration,
axon outgrowth, and synaptogenesis
Serine proteases have been implicated in a variety of develop-
mental processes such as neuronal migration (Seeds et al.,
1990; Friedman and Seeds, 1995), neurite outgrowth (Pittman
et al., 1989; Pittman and DiBenedetto, 1995), and establish-
ment of mature synaptic connections (Hantaı¨ et al., 1989; Liu
et al., 1994). Because it is conceivable that a neuronally ex-
pressed protease inhibitor might serve as a modulator of serine
protease action during nervous system development, the ex-
pression of neuroserpin was analyzed with regard to a spatio-
temporal coincidence with the respective processes. Neuroser-
pin mRNA can be detected in neuronal precursors of most
CNS regions immediately after becoming postmitotic and mi-
grating from the ventricular zones. In the neocortex, neuronal
precursors migrating to the cortical plate express neuroserpin
weakly; neurons that have settled in the cortical plate and
extend axons that eventually establish synaptic contacts, how-
ever, contain larger amounts of neuroserpin mRNA. In the
thalamus, again, neuroserpin expression begins shortly after
neurons have left the neuroepithelium. Expression then con-
tinues at approximately constant levels throughout growth of
thalamocortical fibers, the formation of transient contacts be-
tween axons and subplate neurons, and the ingrowth of tha-
lamic axons into the cortical plate perinatally. Expression of
neuroserpin is downregulated in association and sensory relay
nuclei of the thalamus during or shortly after the period of
projection refinement by synapse elimination. In the cerebel-
lum, neurons of the deep cerebellar nuclei are positive for
neuroserpin mRNA already at the time of axon outgrowth and
their translocation from the surface of the cerebellar primor-
dium into a deeper position; they remain positive during later
development. A subset of Purkinje cells in the cerebellar
hemispheres becomes neuroserpin-positive during their radial
migration from the neuroepithelium to the surface of the
cerebellar primordium. These Purkinje cells continue to ex-
press neuroserpin strongly during the first postnatal week,
when corticonuclear projections have already been established
and granule cells form synaptic contacts with Purkinje cells.
Granule cells synthesize low amounts of neuroserpin shortly
before and higher amounts after their migration from the EGL
to the internal granular layer. Expression in these neurons
declines only after synaptic contacts to Purkinje cells have
been established. In the spinal cord, neurons in the mantle
layer of both the basal and the alar plate become positive for
neuroserpin when the motoneurons and association neurons
extend neurites and the axons of commissural neurons cross
the floor plate. Maximal expression by motoneurons, neurons
of the dorsal horn, and the intermediate zone is, however,
reached during the first week of postnatal development, well
after the major phase of axogenesis and during the period of
synapse elimination at the neuromuscular junction. Taken to-
Figure 7. Neuroserpin mRNA distribution in the developing spinal cord and DRG. Transverse sections of cervical spinal cord at E10.5 (A, B), E13 ( C ),
E15 (D), P0 ( E), P6 ( F ), and P21 ( G). Sections shown in B–G were hybridized with a neuroserpin antisense riboprobe. The section shown in A is a
section adjacent to that in B stained with cresyl violet. The arrowhead in B marks differentiating motoneurons; arrows point to commissural and/or
association neurons. ap, Alar plate; bp, basal plate; dh, dorsal horn; drg, dorsal root ganglion; fp, floor plate; iz, intermediate zone; vh, ventral horn. Scale
bars: B, 100 mm; C, D, 200 mm; E–G, 400 mm.
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gether, these observations indicate that neuroserpin is ex-
pressed during all developmental stages for which an involve-
ment of plasminogen activators has been discussed. Data on
temporal expression of neuroserpin argue in favor of an en-
gagement of neuroserpin in later developmental processes,
such as synaptogenesis or the refinement of synaptic connec-
tions: in some regions of the CNS expression of neuroserpin
mRNA still increases well after the major phases of neuronal
migration and axogenesis. Moreover, the maximal amounts of
neuroserpin protein in the brain are reached only perinatally.
Figure 8. Detection of neuroserpin protein in tissue extracts. A, Neuro-
serpin in extracts of adult mouse tissues. Extracts were prepared from 250
mg of each tissue, and neuroserpin was immunoprecipitated from these
extracts with the monoclonal anti-neuroserpin antibody A15F2 coupled to
Sepharose 4B. Precipitated proteins were subjected to SDS-PAGE and
immunoblotting using a rabbit antiserum against neuroserpin. As a con-
trol for specificity of immunodetection, a brain extract was mock-
precipitated with glycine-quenched, CNBr-activated Sepharose 4B and
immunoblotted (brain/G-S4B). Additionally, A15F2-coupled Sepharose
incubated with homogenization buffer instead of tissue extract was mock-
eluted with SDS-PAGE loading buffer and subjected to Western blot
analysis (–/A15F2-S4B). Positions of molecular weight standards are in-
dicated on the right (in kilodaltons). B, Neuroserpin in extracts of different
brain regions. Extracts of different regions of adult mouse brains were
prepared, and their total protein concentration was adjusted to 5 mg/ml.
From 3 ml of these extracts, neuroserpin was immunoprecipitated and
detected as described above. olf. bulb, Olfactory bulb. C, Neuroserpin in
brain extracts of different developmental stages. Extracts from heads
(E14 ) or total brains (others) of different developmental stages were
prepared, and their total protein concentration was adjusted to 5 mg/ml.
From 3 ml of these extracts, neuroserpin was immunoprecipitated and
detected as described above. Thirty nanograms of recombinant mouse
neuroserpin in 1 ml of homogenization buffer were subjected to the same
immunoprecipitation and immunoblotting procedure (rmNS). Positions
of molecular weight standards are indicated on the right (in kilodaltons).
Figure 9. Inhibitory specificity of neuroserpin. A, Purified recombinant
mouse neuroserpin. Neuroserpin tagged C-terminally with a stretch of six
histidines was recombinantly expressed in E. coli and purified by metal
chelate affinity chromatography. A representative preparation of recom-
binant neuroserpin subjected to SDS-PAGE is shown. Proteins were
visualized by silver staining. Positions of molecular weight standards are
indicated on the right (in kilodaltons). B, Neuroserpin forms SDS-stable
complexes with tPA, uPA, and plasmin but not with thrombin. Recombi-
nant mouse neuroserpin (rmNS) at a concentration of 1 mM was incubated
either alone (1st lane) or together with 0.3 mM or 1 mM of either tPA, uPA,
thrombin (thr), or plasmin (as indicated above). Samples were then
subjected to SDS-PAGE under reducing conditions, and the proteins were
blotted to nitrocellulose. Neuroserpin or protein complexes containing
neuroserpin were detected using an antiserum raised against neuroserpin.
To exclude cross-reactivity of the antiserum toward proteins in the serine
protease samples, equal amounts of the respective proteases were loaded
on the gel without previous addition of neuroserpin (4th, 7th, 10th, 13th
lanes). Positions of molecular weight standards are indicated on the right
(in kilodaltons). C, Neuroserpin inhibits the amidolytic activity of plas-
minogen activators and plasmin but fails to inhibit thrombin. Serine
proteases tPA, uPA, plasmin, and thrombin at a constant concentration of
8 nM were preincubated with various concentrations of purified recombi-
nant neuroserpin. After addition of the protease substrate D-isoleucyl-L-
prolyl-L-arginine-p-nitroaniline samples were incubated at 25°C, and the
velocity of p-nitroaniline liberation was determined by measuring the
extinction of the samples at 405 nm at different time intervals. The
residual amidolytic activity of a protease in a sample containing neuro-
serpin was calculated as the ratio between the initial reaction velocity of
this sample and the initial reaction velocity of a sample not containing
neuroserpin. Experiments were performed in triplicate for every protease
and concentration of neuroserpin. Error bars indicate SD.
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Neuroserpin may act as a regulator of tPA activity in
the nervous system
For an understanding of the function of neuroserpin in nervous
system development or maintenance, it is important to determine
its cognate serine protease(s). Here we show that plasminogen
activators and plasmin, but not thrombin, form SDS-stable com-
plexes and are inhibited by neuroserpin in vitro. Especially, the
amidolytic activity of tPA was shown to be strongly inhibited by
neuroserpin. Intriguingly, this serpin is expressed in many CNS
regions that are also known to express tPA. In the adult rodent
brain, tPA mRNA has been detected not only in ependyma,
meninges, vascular endothelium, and glial cells in many brain
regions, but also in mitral cells and granule cells of the olfactory
bulb (Thewke and Seeds, 1996), in the hippocampal formation in
pyramidal cells of the CA fields and granule cells of the dentate
gyrus (Qian et al., 1993; Sappino et al., 1993), and in granule cells
and Purkinje cells of the cerebellum (Ware et al., 1995; Seeds et
al., 1995). We found neuroserpin to be expressed in the same
structures, although not always by the same neuronal cell popu-
lations. It should be noted, however, that the patterns of mRNA
expression do not allow the conclusion that the corresponding
proteins are colocalized. Two proteins synthesized by a given
neuron may be released at different sites, for example, axon
terminals and dendrites; conversely, two proteins synthesized by
different neurons could be colocalized at a synapse. Therefore, a
decisive answer to the question of a spatio-temporal colocaliza-
tion of neuroserpin and tPA will only become possible once
appropriate antibodies are available for immunohistochemical
localization of the proteins. Besides tPA, other neurally expressed
serine proteases have to be considered as potential cognate pro-
teases of neuroserpin; uPA and plasmin, inhibited by recombinant
neuroserpin to some extent in vitro, were reported to be expressed
in the murine CNS (Sumi et al., 1992; Dent et al., 1993; Tsirka et
al., 1997). Other possible targets for an inhibition by neuroserpin
include neuropsin, a serine protease expressed specifically in the
limbic system of the mouse brain (Chen et al., 1995), and neuro-
trypsin, a recently characterized serine protease expressed neu-
ronally in high levels in the neocortex, olfactory bulb, hippocam-
pus, amygdala, and brain stem motor nuclei (Gschwend et al.,
1997).
Neuroserpin and tPA, a new team on the playground of
neuronal plasticity?
The observation that in many neuronal populations neuroserpin
mRNA and protein can be detected in significant amounts not
only during development but also in the adult prompts specula-
tions about a function of this serine protease inhibitor in the
maintenance of the adult nervous system. Recently, intriguing
findings have been made concerning a possible involvement of
plasminogen activators in the facilitation of neuronal plasticity. It
has been shown that tPA expression and secretion from neurons
are regulated by neuronal activity (Qian et al., 1993; Seeds et al.,
1995; Gualandris et al., 1996), meeting a criterion commonly
proposed for “plasticity-related” proteins. Moreover, it has been
demonstrated that tPA has a function in the maintenance of
long-lasting LTP in the hippocampus (Frey et al., 1996; Huang et
al., 1996), and that a regular performance of animals in learning
tasks appears to depend on a balanced expression of plasminogen
activators in the brain structures involved (Meiri et al., 1994;
Huang et al., 1996). The observation that an overexpression of
plasminogen activator in the hippocampus and in the amygdala
results in a poor performance in spatial and taste aversion tasks
(Meiri et al., 1994) argues in favor of a potential relevance of an
inhibitor of plasminogen activators in these processes. Both the
inhibitory specificity and the spatial distribution of expression are
consistent with a function of neuroserpin in this context. Neuro-
serpin can inhibit the proteolytic activity of tPA. Moreover, it is
most abundantly expressed in neurons of CNS regions that have
been shown to display a high degree of plasticity, i.e., the neo-
cortex (Gilbert, 1992; Merzenich and Sameshima, 1993), the
hippocampal formation (Ben-Ari and Represa, 1990; Larkman
and Jack, 1995), the olfactory formation (Sullivan et al., 1995),
and the amygdala (Maren and Fanselow, 1996). Despite the
cellular and molecular mechanisms by which tPA exerts its func-
tions being ill-defined, and although an involvement of neuroser-
pin in the modulation of synaptic efficacy or structural changes
associated with learning remains to be demonstrated, it is tempt-
ing to speculate that neuroserpin and tPA are complementary
proteins in the facilitation of neuronal plasticity.
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